News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
828,099 Results
Type
Article (83156)
Company Profile (433)
Press Release (744486)
Multimedia
Podcasts (210)
Webinars (32)
Section
Business (217574)
Career Advice (3591)
Deals (38251)
Drug Delivery (163)
Drug Development (90056)
Employer Resources (195)
FDA (18197)
Job Trends (16755)
News (377170)
Policy (38634)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3027)
Academic (2)
Accelerated approval (45)
Adcomms (37)
Allergies (173)
Alliances (54902)
ALS (207)
Alzheimer's disease (1885)
Antibody-drug conjugate (ADC) (415)
Approvals (18429)
Artificial intelligence (701)
Autoimmune disease (249)
Automation (53)
Bankruptcy (388)
Best Places to Work (12499)
BIOSECURE Act (23)
Biosimilars (219)
Biotechnology (292)
Bladder cancer (186)
Brain cancer (73)
Breast cancer (730)
Cancer (5662)
Cardiovascular disease (503)
Career advice (3076)
Career pathing (46)
CAR-T (331)
CDC (71)
Celiac Disease (2)
Cell therapy (901)
Cervical cancer (43)
Clinical research (76709)
Collaboration (2080)
Company closure (7)
Compensation (1313)
Complete response letters (91)
COVID-19 (3009)
CRISPR (110)
C-suite (1054)
Cystic fibrosis (159)
Data (7249)
Decentralized trials (3)
Denatured (75)
Depression (176)
Dermatology (59)
Diabetes (590)
Diagnostics (7355)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (346)
Drug pricing (237)
Drug shortages (37)
Duchenne muscular dystrophy (286)
Earnings (91238)
Editorial (71)
Employer branding (25)
Employer resources (168)
Events (127280)
Executive appointments (1111)
FDA (21760)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1734)
Gene editing (238)
Generative AI (69)
Gene therapy (748)
GLP-1 (1206)
Government (5450)
Grass and pollen (8)
Guidances (400)
Healthcare (20874)
HIV (79)
Huntington's disease (58)
IgA nephropathy (96)
Immunology and inflammation (327)
Immuno-oncology (92)
Indications (158)
Infectious disease (3353)
Inflammatory bowel disease (223)
Inflation Reduction Act (17)
Influenza (139)
Intellectual property (283)
Interviews (685)
IPO (17628)
IRA (61)
Job creations (4613)
Job search strategy (2488)
JPM (73)
Kidney cancer (19)
Labor market (98)
Layoffs (668)
Leadership (45)
Legal (9689)
Liver cancer (106)
Longevity (29)
Lung cancer (759)
Lymphoma (417)
Machine learning (54)
Management (65)
Manufacturing (1004)
MASH (194)
Medical device (14978)
Medtech (15059)
Mergers & acquisitions (21812)
Metabolic disorders (1588)
mRNA (215)
Multiple sclerosis (182)
NASH (24)
Neurodegenerative disease (436)
Neuropsychiatric disorders (116)
Neuroscience (3412)
Neurotech (2)
NextGen: Class of 2026 (7500)
Non-profit (5115)
Now hiring (72)
Obesity (778)
Opinion (355)
Ovarian cancer (190)
Pain (248)
Pancreatic cancer (268)
Parkinson's disease (364)
Partnered (38)
Patents (583)
Patient recruitment (620)
Peanut (65)
People (64438)
Pharmaceutical (86)
Pharmacy benefit managers (36)
Phase 1 (23638)
Phase 2 (33349)
Phase 3 (25156)
Pipeline (7322)
Policy (367)
Postmarket research (3450)
Preclinical (10548)
Press Release (69)
Prostate cancer (291)
Psychedelics (61)
Radiopharmaceuticals (329)
Rare diseases (1114)
Real estate (6953)
Recruiting (81)
Regulatory (28823)
Reports (62)
Research institute (2739)
Resumes & cover letters (576)
Rett syndrome (33)
RNA editing (22)
RSV (94)
Schizophrenia (178)
Series A (292)
Series B (214)
Service/supplier (18)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (185)
Sponsored (51)
Startups (4132)
State (2)
Stomach cancer (21)
Supply chain (129)
Tariffs (102)
The Weekly (132)
Vaccines (1226)
Venture capital (111)
Weight loss (529)
Women's health (116)
Worklife (23)
Date
Last 7 days (678)
Last 30 days (2682)
Last 365 days (32167)
2026 (8582)
2025 (32536)
2024 (37445)
2023 (42320)
2022 (53673)
2021 (58420)
2020 (57354)
2019 (50988)
2018 (38837)
2017 (36557)
2016 (36991)
2015 (42681)
2014 (36831)
2013 (34141)
2012 (35063)
2011 (35098)
2010 (34640)
Location
Africa (1170)
Alabama (99)
Alaska (7)
Arizona (341)
Arkansas (15)
Asia (49224)
Australia (8586)
California (12656)
Canada (3592)
China (1334)
Colorado (537)
Connecticut (552)
Delaware (382)
Europe (114632)
Florida (1899)
Georgia (409)
Hawaii (4)
Idaho (69)
Illinois (1059)
India (87)
Indiana (583)
Iowa (23)
Japan (505)
Kansas (137)
Kentucky (47)
Louisiana (44)
Maine (85)
Maryland (1567)
Massachusetts (9237)
Michigan (375)
Minnesota (717)
Mississippi (7)
Missouri (154)
Montana (37)
Nebraska (29)
Nevada (142)
New Hampshire (90)
New Jersey (3409)
New Mexico (33)
New York (3364)
North Carolina (1703)
North Dakota (10)
Northern California (6211)
Ohio (389)
Oklahoma (25)
Oregon (46)
Pennsylvania (2543)
Puerto Rico (27)
Rhode Island (53)
South America (1560)
South Carolina (78)
South Dakota (1)
Southern California (4955)
Tennessee (205)
Texas (2022)
United States (45451)
Utah (383)
Vermont (1)
Virginia (319)
Washington D.C. (87)
Washington State (1037)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
828,099 Results for "st luke s roosevelt and continuum cancer centers".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FIRST ON THE WEST COAST: Eisenhower Lucy Curci Cancer Center Earns Lung Cancer Certification from The Joint Commission
March 20, 2026
·
3 min read
Collaboration
Astellas Bets up to $1.7B for Vir’s ‘Robust Competitor’ in Prostate Cancer
In a Phase 1 study, 82% of patients on VIR-5500 achieved at least a 50% reduction in PSA levels—a result analysts praised as competitive in the prostate cancer space.
February 24, 2026
·
2 min read
·
Tristan Manalac
Adcomms
Two AstraZeneca Drugs To Be Scrutinized in First FDA Cancer Advisory Panel in 9 Months
The FDA’s cancer advisors will discuss AstraZeneca’s application for the oral SERD camizestrant in breast cancer and the AKT inhibitor Truqap in prostate cancer.
March 9, 2026
·
3 min read
·
Tristan Manalac
Press Releases
RenovoRx Expands RenovoCath® Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center
January 20, 2026
·
11 min read
Press Releases
Tampa General Hospital and USF Health Named Cancer Center of Excellence in Florida
March 24, 2026
·
8 min read
Press Releases
SignaBlok to Present Novel Approach to Preventing Cancer Recurrence at the 2026 American Association for Cancer Research (AACR) Annual Meeting
Ligand-independent mechanism of action of SignaBlok’s first-in-class TREM-1 inhibitors enables development of cell-unspecific and macrophage-targeted TREM-1 inhibitors · In experimental pancreatic cancer, macrophage-targeted but not cell-unspecific TREM-1 inhibitor: − prevents cancer recurrence, improves complete response rate and survival, when administered in a time window of 7 days after standard-of-care (SOC) chemotherapy − reverses immunosuppression and overcomes cancer resistance to anti-PD-L1 immunotherapy · Timely resolution of acute inflammation induced by SOC cancer treatments (chemotherapy, surgery, radiation, radiopharmaceuticals, etc.) can be a common approach to prevent cancer recurrence, increase response rate and survival for not only pancreatic cancer but also other hard-to-treat tumors
March 26, 2026
·
1 min read
Press Releases
U.S. Patient with Advanced Lung Cancer Stabilized by Novel Immunotherapy Treatment in China
March 9, 2026
·
1 min read
Press Releases
Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay
March 10, 2026
·
6 min read
Press Releases
Northwell Health and START Center for Cancer Research unveil world-class early-phase cancer clinical trial center
December 18, 2025
·
5 min read
BioMidwest
Medline signs strategic partnership with St. Luke’s in Duluth, MN
Medline has announced the signing of a five-year primary supplier vendor agreement with St. Luke’s, headquartered in Duluth, Minnesota.
January 31, 2024
·
2 min read
Previous
2 of 82,810
Next